UA2239 is an antimalarial agent that falls under the category of acyclic nucleoside phosphonates. It disrupts essential cGMP-dependent exocytosis pathways by reducing cGMP levels and specifically targets guanylyl cyclase alpha (guanylyl cyclase alpha). UA2239 exhibits a rapid and irreversible inhibitory effect on Plasmodium parasites.
